EugeneChambersMD

Summary

• Chip Chambers, M.D., is the founder and president of the board of directors of the DADA2 Foundation. As a physician and educator with years of experience in the business sector of healthcare, he is unusually well prepared to lead the DADA2 Foundation that forges productive and innovative partnerships between clinicians, researchers, and patients. He is a compelling advocate for rare disease patients, a tireless networker, and the co-author of multiple scientific papers on Deficiency of Adenosine Deaminase 2 (DADA2). Dr. Chambers two children were diagnosed with the rare disease DADA2 in March 2014, just 1 month after the first articles describing the disease were published in the New England Journal of Medicine. Dr. Chambers is the former Chief of Endocrine Surgery at Vanderbilt University Medical Center in Nashville, Tennessee, where he continues to hold his clinical faculty appointment. He received his M.D. from the University of Mississippi. He was recently named to the newly created Tennessee Rare Disease Advisory Council by Governor Bill Lee.